| Literature DB >> 26342081 |
Sophie Trefely1, Poh-Sim Khoo2, James R Krycer3, Rima Chaudhuri3, Daniel J Fazakerley3, Benjamin L Parker3, Ghazal Sultani1, James Lee4, Jean-Philippe Stephan4, Eric Torres4, Kenneth Jung4, Coenraad Kuijl4, David E James5, Jagath R Junutula6, Jacqueline Stöckli7.
Abstract
The insulin/insulin-like growth factor (IGF)-1 signaling pathway (ISP) plays a fundamental role in long term health in a range of organisms. Protein kinases including Akt and ERK are intimately involved in the ISP. To identify other kinases that may participate in this pathway or intersect with it in a regulatory manner, we performed a whole kinome (779 kinases) siRNA screen for positive or negative regulators of the ISP, using GLUT4 translocation to the cell surface as an output for pathway activity. We identified PFKFB3, a positive regulator of glycolysis that is highly expressed in cancer cells and adipocytes, as a positive ISP regulator. Pharmacological inhibition of PFKFB3 suppressed insulin-stimulated glucose uptake, GLUT4 translocation, and Akt signaling in 3T3-L1 adipocytes. In contrast, overexpression of PFKFB3 in HEK293 cells potentiated insulin-dependent phosphorylation of Akt and Akt substrates. Furthermore, pharmacological modulation of glycolysis in 3T3-L1 adipocytes affected Akt phosphorylation. These data add to an emerging body of evidence that metabolism plays a central role in regulating numerous biological processes including the ISP. Our findings have important implications for diseases such as type 2 diabetes and cancer that are characterized by marked disruption of both metabolism and growth factor signaling.Entities:
Keywords: Akt PKB; PFKFB3; Warburg effect; glucose metabolism; glucose transporter type 4 (GLUT4); glycolysis; insulin
Mesh:
Substances:
Year: 2015 PMID: 26342081 PMCID: PMC4646237 DOI: 10.1074/jbc.M115.658815
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157